Sensei reengineers the badass bacteriophage into a personalized vaccine for tough human cancers: SenseiBio.com (NASDAQ: SNSE)

Today is World Cancer Day, a reminder of the global need.

FD: Our portfolio company Cambrian is the largest shareholder (20%), and Future Ventures directly is the 3rd largest shareholder in Sensei.

5 responses to “CONGRATULATIONS to to cancer vaccine company Sensei Bio on their successful IPO today!”

  1. earlier post on the Sensei technologyPutting Phage to Work — Interspecies Immunology The viral capsid is both a cheaply-manufactured nanoparticle and a natural adjuvant for a complete, effective and safe vaccine (the phage cannot infect human cells and are inactivated).

  2. Steve, As someone who has had cancer and lost a parent at a very young age to cancer I can’t think of a better goal for mankind. Thank you for supporting this.

  3. Someday, the way we treat cancers today is going to look like Gold Rush era dentistry. I look forward to things like chemotherapy being obsoleted.

  4. Thanks. They are doing important work. We are deeply appreciative of what the team at Sensei are doing to help forge a better future, one that many might not think possible.

    P.S. Nice shout out from the CEO of Sensei this morning:

Leave a Reply

Your email address will not be published. Required fields are marked *